Quest Diagnostics, Inc. (DGX) Posts Mixed Q2 Results; Guides FY11 EPS In-Line
Tweet
Share
E-mailGet Alerts DGX Hot Sheet
Price: $209.88 +1.76%
Revenue Growth %: +8.0%
Financial Fact:
Total non-operating expenses, net: -33M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +8.0%
Financial Fact:
Total non-operating expenses, net: -33M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Quest Diagnostics, Inc. (NYSE: DGX) reported Q2 adjusted EPS of $1.17, $0.04 better than the analyst estimate of $1.13. Revenue for the quarter came in at $1.9 million versus the consensus estimate of $1.92 billion.
Quest Diagnostics, Inc. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.33.
Quest Diagnostics, Inc. sees FY2011 EPS of $4.25-$4.35, versus the consensus of $4.33.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
- GameStop 'remains focused on advancing' proposed eBay deal, offers adjusted EBITDA guidance - Filing
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
